Lockie Christopher J A, Gillon Stuart A, Barrett Nicholas A, Taylor Daniel, Mazumder Asif, Paramesh Kaggere, Rowland Katie, Daly Kathleen, Camporota Luigi, Meadows Christopher I S, Glover Guy W, Ioannou Nicholas, Langrish Christopher J, Tricklebank Stephen, Retter Andrew, Wyncoll Duncan L A
1Department of Critical Care, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. 2Department of Critical Care, Queen Elizabeth University Hospital, Glasgow, United Kingdom. 3Department of Radiology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Crit Care Med. 2017 Oct;45(10):1642-1649. doi: 10.1097/CCM.0000000000002579.
For patients supported with veno-venous extracorporeal membrane oxygenation, the occurrence of intracranial hemorrhage is associated with a high mortality. It is unclear whether intracranial hemorrhage is a consequence of the extracorporeal intervention or of the underlying severe respiratory pathology. In a cohort of patients transferred to a regional severe respiratory failure center that routinely employs admission brain imaging, we sought 1) the prevalence of intracranial hemorrhage; 2) survival and neurologic outcomes; and 3) factors associated with intracranial hemorrhage.
A single-center, retrospective, observational cohort study.
Tertiary referral severe respiratory failure center, university teaching hospital.
Patients admitted between December 2011 and February 2016.
None.
Three hundred forty-two patients were identified: 250 managed with extracorporeal support and 92 managed using conventional ventilation. The prevalence of intracranial hemorrhage was 16.4% in extracorporeal membrane oxygenation patients and 7.6% in conventionally managed patients (p = 0.04). Multivariate analysis revealed factors independently associated with intracranial hemorrhage to be duration of ventilation (d) (odds ratio, 1.13 [95% CI, 1.03-1.23]; p = 0.011) and admission fibrinogen (g/L) (odds ratio, 0.73 [0.57-0.91]; p = 0.009); extracorporeal membrane oxygenation was not an independent risk factor (odds ratio, 3.29 [0.96-15.99]; p = 0.088). In patients who received veno-venous extracorporeal membrane oxygenation, there was no significant difference in 6-month survival between patients with and without intracranial hemorrhage (68.3% vs 76.0%; p = 0.350). Good neurologic function was observed in 92%.
We report a higher prevalence of intracranial hemorrhage than has previously been described with high level of neurologically intact survival. Duration of mechanical ventilation and admission fibrinogen, but not exposure to extracorporeal support, are independently associated with intracranial hemorrhage.
对于接受静脉-静脉体外膜肺氧合支持的患者,颅内出血的发生与高死亡率相关。目前尚不清楚颅内出血是体外干预的结果还是潜在严重呼吸疾病的结果。在一组转至常规进行入院脑成像检查的地区性严重呼吸衰竭中心的患者中,我们旨在:1)确定颅内出血的患病率;2)生存及神经学转归;3)与颅内出血相关的因素。
单中心、回顾性、观察性队列研究。
三级转诊严重呼吸衰竭中心,大学教学医院。
2011年12月至2016年2月期间入院的患者。
无。
共纳入342例患者:250例接受体外支持治疗,92例采用传统通气治疗。体外膜肺氧合患者颅内出血的患病率为16.4%,传统治疗患者为7.6%(p = 0.04)。多因素分析显示,与颅内出血独立相关的因素为通气时间(d)(比值比,1.13 [95% CI,1.03 - 1.23];p = 0.011)及入院时纤维蛋白原水平(g/L)(比值比,0.73 [0.57 - 0.91];p = 0.009);体外膜肺氧合不是独立危险因素(比值比,3.29 [0.96 - 15.99];p = 0.088)。在接受静脉-静脉体外膜肺氧合的患者中,有颅内出血和无颅内出血患者的6个月生存率无显著差异(68.3% 对76.0%;p = 0.350)。92%的患者神经功能良好。
我们报告的颅内出血患病率高于以往描述,且神经功能完好的生存率较高。机械通气时间和入院时纤维蛋白原水平与颅内出血独立相关,而体外支持治疗与之无关。